Important: New Login Process

We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.

  • If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
  • If you log in with a username and password, you will be prompted to set a new password before accessing your account.

Go to the Login Page to get started.

We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.

BioCentury
ARTICLE | Company News

InteRNA Technologies, Silence Therapeutics deal

September 19, 2011 7:00 AM UTC

The companies partnered to develop microRNA therapeutics to treat cancer. InteRNA will provide specific miRNA sequences which Silence will formulate with its AtuPLEX delivery system to develop multiple drug candidates. The partners will conduct preclinical studies before selecting lead candidates. Silence is eligible to receive upfront payments plus milestones. Details were not disclosed. ...

Get Unlimited Access
Continue reading with a free trial.
Or Purchase This Article